Biomarin Pharmaceutical Inc. - Registered Shares

NASDAQ:BMRN  
81.97
-1.01 (-1.22%)
Debt Financing / Related

Biomarin Pharmaceutical Says Entered An Amendment Agreement In Respect Of Credit Agreement, Dated As Of Oct. 19, 2018

Published: 06/02/2021 10:35 GMT
Biomarin Pharmaceutical Inc. - Registered Shares (BMRN) - Biomarin Pharmaceutical - on May 28, 2021, Co Entered an Amendment Agreement in Respect of Its Credit Agreement, Dated As of October 19, 2018.
Biomarin Pharmaceutical - Entered an Amendment Agreement to Extend Maturity Date of Revolving Credit Facility to May 28, 2024.
Biomarin Pharmaceutical Inc - Credit Agreement Provides for Up to $200 Million in Revolving Loans, None of Which Was Drawn at Closing.
Biomarin Pharmaceutical - Co Expects to Use Proceeds of Credit Facility to Finance Ongoing Working Capital Needs, for Other General Corporate Purposes.